Condition: Multiligament Knee Injuries · Sponsor: Tissue Regenix Ltd
To monitor residual risks in the post-market phase and to ensure continued clinical evaluation of the device safety and performance to ensure that no new or unexpected risks arise when used during multi-ligament knee reconstructions.
This description comes directly from the study's public registry record.
Anna Kaniewska · +44 (0)3304303052 · a.kaniewska@tissueregenix.com
Always discuss trial participation with your own doctor first.
| Royal Stoke University Hospital | Stoke-on-Trent, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05655156